Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glenn A Doyle

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 15, 2015
Somatic DNA Variation in Brain as a Source of Risk for CNS DiseasesGlenn A Doyle, Wade H Berrettini
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 11, 2017
Failure to Replicate an Association of a LINE-1 Element in ERI1 Exoribonuclease Family Member 3 (ERI3) with SchizophreniaGlenn A Doyle, Wade H Berrettini
Cancer Research|January 20, 2004
Mammary tumor induction in transgenic mice expressing an RNA-binding proteinCharles R Tessier, Glenn A Doyle, Brad A Clark, et al.
Cold Spring Harbor Perspectives in Medicine|April 2, 2020
Neonatal Opioid Withdrawal Syndrome (NOWS): A Transgenerational Echo of the Opioid CrisisAndrew E Weller, Richard C Crist, Benjamin C Reiner, et al.
Neuroscience Research|November 10, 2021
Analysis of differential gene expression and transcript usage in hippocampus of Apoe null mutant mice: Implications for Alzheimer's diseaseAndrew E Weller, Glenn A Doyle, Benjamin C Reiner, et al.
The American Journal of Drug and Alcohol Abuse|January 16, 2018
Pharmacogenetic analysis of opioid dependence treatment dose and dropout rateRichard C Crist, James Li, Glenn A Doyle, et al.
Neuropharmacology|March 23, 2025
Modulation of mu-opioid receptor function alters electroshock seizure responses in miceThomas N Ferraro, James R DeChiara, Ruoyu Chen, et al.
The American Journal of Drug and Alcohol Abuse|August 19, 2021
Differential expression and transcription factor binding associated with genotype at a pharmacogenetic variant in <i>OPRD1</i>Richard C Crist, Gabriella Arauco-Shapiro, Alexander Zhang, et al.
Neuroscience Research|April 29, 2006
Identification and functional significance of polymorphisms in the mu-opioid receptor gene (Oprm) promoter of C57BL/6 and DBA/2 miceGlenn A Doyle, X Rebecca Sheng, Candice L Schwebel, et al.
Psychiatric Genetics|April 1, 2014
Identification of CHRNA5 rare variants in African-American heavy smokersGlenn A Doyle, Andrew D Chou, Wint Thu Saung, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 15, 2015
Somatic DNA Variation in Brain as a Source of Risk for CNS DiseasesGlenn A Doyle, Wade H Berrettini
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 11, 2017
Failure to Replicate an Association of a LINE-1 Element in ERI1 Exoribonuclease Family Member 3 (ERI3) with SchizophreniaGlenn A Doyle, Wade H Berrettini
Cancer Research|January 20, 2004
Mammary tumor induction in transgenic mice expressing an RNA-binding proteinCharles R Tessier, Glenn A Doyle, Brad A Clark, et al.
Cold Spring Harbor Perspectives in Medicine|April 2, 2020
Neonatal Opioid Withdrawal Syndrome (NOWS): A Transgenerational Echo of the Opioid CrisisAndrew E Weller, Richard C Crist, Benjamin C Reiner, et al.
Neuroscience Research|November 10, 2021
Analysis of differential gene expression and transcript usage in hippocampus of Apoe null mutant mice: Implications for Alzheimer's diseaseAndrew E Weller, Glenn A Doyle, Benjamin C Reiner, et al.
The American Journal of Drug and Alcohol Abuse|January 16, 2018
Pharmacogenetic analysis of opioid dependence treatment dose and dropout rateRichard C Crist, James Li, Glenn A Doyle, et al.
Neuropharmacology|March 23, 2025
Modulation of mu-opioid receptor function alters electroshock seizure responses in miceThomas N Ferraro, James R DeChiara, Ruoyu Chen, et al.
The American Journal of Drug and Alcohol Abuse|August 19, 2021
Differential expression and transcription factor binding associated with genotype at a pharmacogenetic variant in <i>OPRD1</i>Richard C Crist, Gabriella Arauco-Shapiro, Alexander Zhang, et al.
Neuroscience Research|April 29, 2006
Identification and functional significance of polymorphisms in the mu-opioid receptor gene (Oprm) promoter of C57BL/6 and DBA/2 miceGlenn A Doyle, X Rebecca Sheng, Candice L Schwebel, et al.
Psychiatric Genetics|April 1, 2014
Identification of CHRNA5 rare variants in African-American heavy smokersGlenn A Doyle, Andrew D Chou, Wint Thu Saung, et al.
Pageof 4